Market Analysis and Insights: Global Pediatric Vaccines Market
The global Pediatric Vaccines market was valued at US$ 32340 in 2020 and will reach US$ 45100 million by the end of 2027, growing at a CAGR of 5.7% during 2022-2027.

Global Pediatric Vaccines Scope and Market Size
The global Pediatric Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Others

Segment by Application
Newborn
Infant
Child
Dolescent

The Pediatric Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Pediatric Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin
S K Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
Sinovac Biotech
Bharat Biotech
Crucell
Dynavax
Serum Institute of India